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AbstrAct
Objectives To analyse free-text responses from the first 
Scottish Cancer Patient Experience Survey (SCPES) to 
understand patients’ experiences of care, identify valued 
aspects and areas for improvement.
Design Inductive thematic analysis of seven free-
text comment boxes covering all stages of the cancer 
experience, from a national cohort survey.
Setting and participants Adult cancer patients 
diagnosed across all Health Boards in Scotland between 
July 2013 and March 2014, and who had an inpatient 
stay or hospital visit between January and September 
2014. 2663 respondents (of n=4835 survey respondents) 
provided 6961 free-text comments.
Main outcome measures Positive and negative themes 
of patients’ experiences. Differences in the proportion of 
positive to negative comments by demographics.
Methods Data were analysed as follows: (1) comments 
were initially categorised at a high level (eg, positive, 
negative, miscellaneous, etc); (2) inductive codes 
were derived and applied to all relevant comments; 
(3) codes sharing similar meaning were amalgamated 
into subthemes, and code frequencies were measured; 
(4) subthemes were mapped into overarching themes; 
(5) difference in the proportion of positive to negative 
comments by demographics were analysed using χ2 tests.
Results Participants made more positive than negative 
comments (1:0.78). Analysis highlighted the importance 
to patients of Feeling that Individual Needs Are Met and 
Feeling Confident Within the System. Comments also 
provided insight into how Processes and Structures within 
the system of care can negatively impact on patients’ 
experience. Particular issues were identified with care 
experiences in the lead-up to diagnosis.
Conclusions This analysis provides a detailed 
understanding of patients’ cancer care experiences, 
therefore indicating what aspects matter in those 
experiences. Although the majority of comments were 
positive, there were a significant number of negative 
comments, especially about the lead-up to diagnosis. 
Comments suggest patients would value greater 
integration of care from services involved in their 
treatment for cancer.
IntroductIon
Finding ways to deliver high-quality, 
person-centred care is central to National 
Health Service (NHS) policy, and has been 
driven by rising demands, financial pres-
sures, concerns about standards of care and 
a greater focus on the ‘consumer’s’ perspec-
tive.1 Patient experience is recognised as one 
of the critical elements of high-quality health-
care, along with clinical effectiveness and 
safety.2 Not just important in itself, patient 
experience has been shown to be positively 
associated with a range of health, resource 
use and safety outcomes.3 In NHS England, 
a measure of patient experience is included 
as one of four key metrics contributing to 
each Clinical Commissioning Group’s overall 
rating for cancer care.4 Assessing the patient’s 
perspective provides valuable insights into 
how the whole healthcare system impacts 
on the patient’s experience across the care 
continuum, rather than looking at individual 
services in isolation from a clinical or hospital 
management standpoint.5
Cancer remains a leading cause of death 
worldwide and will affect one in two people 
in the UK during their lifetime.6 For many 
patients, being diagnosed and treated for 
cancer is a long and complicated process, 
involving multiple stages of investigation and 
treatment, and multiple encounters with a 
variety of health professionals and services. 
Several surveys have been conducted by 
researchers to gain a better understanding of 
experience of care for patients with cancer, 
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Research
Strengths and limitations of this study
 ► Large data set from a national survey.
 ► Use of seven free-text comment boxes gives 
patients a chance to comment on all aspects of the 
cancer patient experience.
 ► Analysis by each comment box gave clear indication 
of stages of care which are of specific concern.
 ► Analysis across the whole data set identified themes 
about their cancer care which are of particular 
importance to patients.
 ► Free-text responses to surveys may not be 
representative of all patients’ experiences.
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although the majority of these look at particular aspects of 
the care trajectory, for example, follow-up care,7 hospital 
care,8 or at specific types of cancer, for example, breast,9 
lung and colorectal.10
National Cancer Patient Experience Surveys have been 
carried out every 18–20 months in England since 2010,11 
and also in Norway,12 Northern Ireland13 and Wales.14 
This is the first time such a survey has been conducted in 
Scotland. The quantitative results of the Scottish Cancer 
Patient Experience Survey (SCPES) were published in 
June 2016, highlighting that the majority of patients have a 
positive experience of care overall, and that many aspects 
of care provision are working well.15 However, the results 
also draw attention to particular areas of care which are 
less positive and require service improvement.15
Previous research has found that clinical staff find 
quantitative data of limited use in designing service 
improvements as they do not provide a sufficiently 
detailed description of the issues which matter to 
patients.16 Including free-text comments in experience 
surveys has the potential to overcome this problem, 
giving the patient a voice to influence service improve-
ment.17 Data from free-text comments can give patients 
the opportunity to explain their experiences in more 
detail, providing deeper insights into patients’ experi-
ences, in particular providing an opportunity for patients 
to be critical of specific aspects of their care.17 Previous 
UK national surveys have included three brief opportu-
nities for free-text comments, asking ‘was there anything 
particularly good about your NHS cancer care?’, ‘was 
there anything that could have been improved?’ and ‘any 
other comments?’ at the end of the survey.18 The SCPES 
steering group made a decision to include a free-text ques-
tion at the end of each section of the survey, providing an 
opportunity for patients to write about different aspects 
of their cancer care in more detail.
The present paper reports on the thematic analysis of 
all free-text comments provided by participants in the 
2015–2016 SCPES. The purpose of the analysis was to 
understand the full breadth of experiences of care for 
patients with cancer in their own words, and from this to 
identify the aspects of the cancer care experience which 
participants particularly valued, and also to explore 
themes which highlight areas for improvement in cancer 
services.
Methods
study design
Data gathering for SCPES took place between 7 October 
2015 and 22 January 2016. Jointly funded by the Scottish 
Government and Macmillan Cancer Support, the survey 
was posted to all NHS Scotland patients who met the 
following inclusion criteria:
 ► Diagnosed with any cancer between July 2013 and 
March 2014.
 ► Had an inpatient stay or hospital visit as a day case 
between 1 January and 30 September 2014.
In total, 7949 survey packs were sent. Two reminder 
letters were sent to non-responders after 3 weeks and 6 
weeks. Patients could respond to the survey via freepost 
return, or by completing the survey online.
survey
The survey questionnaire was based on the equivalent 
English National Cancer Patient Experience Survey,18 with 
69 questions covering referral to hospital by the general 
practitioner (GP), diagnosis, decisions about treatment, 
role of the clinical nurse specialist, support for people 
with cancer, hospital doctors and ward nurses, hospital 
care and treatment, radiotherapy and chemotherapy, 
home care and support, care from general practice and 
overall NHS care. In addition, seven free-text comment 
boxes were included throughout the questionnaire asking 
participants if there was anything else they would like to 
add about their experiences in relation to seven areas of 
care (table 1). Demographic and clinical information 
were collected including gender, age, socioeconomic 
Table 1 Comment boxes
Question topic: is there anything else you 
would like to tell us about… Preceding questionnaire section headings
Comment box 1 The lead-up to your cancer diagnosis, or the 
way you found out you had cancer
Seeing your GP, diagnostic tests, finding out what 
was wrong with you
Comment box 2 The way decisions were made about your 
treatment
Deciding the best treatment for you
Comment box 3 The support you received (including from a 
clinical nurse specialist)
Clinical nurse specialist,
support for people with cancer
Comment box 4 The care you received when you had an 
operation or stayed overnight in hospital
Operations, hospital care as an inpatient
Comment box 5 The day patient/outpatient care you received Hospital care as a day patient/outpatient
Comment box 6 Your chemotherapy/radiotherapy treatment Radiotherapy and chemotherapy
Comment box 7 Your experiences of cancer care Home care and support, care from your general 
practice, your overall NHS care
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status (using the Scottish Index of Multiple Deprivation 
(SIMD)), ethnicity, sexual orientation, employment 
status and tumour group. Anonymised data were trans-
ferred from the Scottish Government to the researchers, 
using encrypted software.
Governance
The approvals process for the survey was led by the Infor-
mation Services Division (ISD). Approval for analysis of 
the fully anonymised comments by the research team was 
given by the Public Benefits and Privacy Panel (http://
www. informationgovernance. scot. nhs. uk/ pbpphsc).
Analysis
Qualitative analysis
Free-text comments were analysed using thematic anal-
ysis,19 employing an inductive approach—coding and 
theme development were driven by the content of the 
comments. Analysis of the large data set was carried out 
using a structured approach.20 The data were divided into 
responses for each of the comment boxes, creating seven 
data sets. These data sets were initially analysed separately, 
before being considered as a whole during the creation 
of themes. One researcher (MC) familiarised herself 
with the data for each comment box by reading all of the 
responses. Notes were made of any potential codes for 
each individual data set by identifying recurring words or 
units of meaning. A second researcher (MW) familiarised 
herself with a random sample of the responses and the 
two researchers discussed and agreed coding decisions. In 
order to further structure the data, responses were sorted 
into first order codes based on whether the comment was 
(1) positive; (2) negative; (3) entirely factual/neutral, for 
example, ‘no treatment required after operation’; (4) 
entirely irrelevant/miscellaneous, for example, ‘oper-
ation at (hospital name removed)’; (5) contained both 
positive and negative comments. If a comment contained, 
for example, both positive and neutral content, it would 
be coded as a positive comment. Comments which were 
entirely factual/neutral or irrelevant/miscellaneous 
were not included in further analysis. MC then applied 
second order codes to all remaining comments in each 
individual data set. Because the second order codes 
had been derived inductively from the data, the coding 
sheet was different for each of the seven data sets. In 
total, there were 174 second order codes across the seven 
comment boxes. Comments were given as many codes as 
were appropriate to cover the content of the comment, 
for example, the comment ‘Food and ward hygiene were 
disgusting’ was given the first order code ‘negative’ and 
the second order codes ‘bad food’ and ‘hygiene issues’. 
Comments were then grouped by second order code and 
reread and compared in order to check for consistency of 
meaning within the code. During this process of constant 
comparison, codes were amalgamated, or new codes 
were created as differences in meaning were identified. 
A third researcher (PA) checked first and second order 
coding decisions for a random 5% of the comments. Any 
discrepancies or disagreements (of which there were 
only a small number) were discussed by the team, and 
adjustments made if necessary. Two researchers (MC and 
MW) worked together to compare, contrast and consol-
idate codes by identifying similar codes and discussing 
differences across the seven comment boxes. Many codes 
that were identified in particular comment boxes also 
emerged in other comment boxes, indicating that there 
were recurring issues that were relevant to all aspects of 
the cancer experience. Therefore, codes which shared 
similar meaning were amalgamated into subthemes. For 
example, the codes ‘hygiene issues’, ‘uncomfortable envi-
ronment’, ‘unhygienic, noisy, bad food’, ‘uncomfortable 
environment’, ‘bad food’, ‘too noisy’, ‘poor facilities’, 
‘bad food, food not as recommended’, ‘poor facilities/
uncomfortable’ and ‘problems with ward environment’, 
which emerged across the comment boxes, were amal-
gamated into the subtheme ‘unsuitable or uncomfortable 
environment’. The subthemes were therefore relevant 
to all aspects of the patients’ experience of care. Code 
frequencies were measured to give an indication of the 
prominence of different subthemes. Subthemes were 
then mapped by MW and MC into overarching themes 
which encompassed and described the main issues high-
lighted in the data. Several subthemes were related to 
patients’ perceptions of the way care was organised, and 
the other subthemes were related to how patients actually 
experienced their care.
Subthemes are illustrated with quotes in tables 2 and 
3. In order to preserve context, comments have been 
presented in full. This may mean in some cases that 
quotes represent more subthemes than the one they are 
presented next to in the table. An individual respondent 
could contribute to more than one subtheme if their 
free-text comment covered several issues. The number 
of comments reported in the tables are the number 
of comments which included information for each 
subtheme.
Quantitative analysis
First order positive and negative coding for each of the 
comments were analysed by key demographics—gender, 
age, socioeconomic status, employment status, tumour 
group and health board—using χ2 tests. The propor-
tion of participants who made a positive comment was 
compared with the proportion who made a negative 
comment across each demographic category, for each of 
the comment boxes. Standardised adjusted residuals were 
calculated for each of the cells of data in order to identify 
which differences between observed and expected cell 
counts contributed to statistically significant χ2 results. 
Standardised adjusted residuals of ≥1.96 indicate there is 
a statistically significant difference between the number 
of cases observed in that cell, and the number expected if 
the null hypothesis is true, that is, that the demographic 
has no bearing on the proportion of positive and negative 
comments.
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Participants who made comments which were both 
positive and negative, or who made factual/neutral or 
irrelevant/miscellaneous comments were excluded from 
this analysis. The χ2 tests were not performed for ethnicity 
and sexual orientation due to the low number of respon-
dents for these demographics.
Due to the low number of respondents in certain cate-
gories, brain, central nervous system and sarcoma cancer 
types were merged, as were the age bands 16–25 years and 
26–35 years. Comments from three rural health boards 
(NHS Orkney, NHS Shetland and NHS Western Isles) 
were omitted due to having less than five respondents 
who made at least one free-text comment.
FIndInGs
Four thousand eight hundred and thirty-five patients 
completed the survey, a 61% response rate. Of those 
patients, 2663 (55%) left at least one free-text comment. 
There were differences in clinical or sociodemographic 
characteristics between those respondents who left at least 
one comment, and those respondents to the survey who 
left no comment (table 4). Women, respondents aged 
35–44 years and 45–54 years and part-time workers were 
more likely to leave a comment and respondents aged 
76 years and over, those who were retired, those from 
the most deprived areas, and respondents with prostate 
cancer or cancer from an unknown tumour group were 
less likely to leave a comment. In total 6961 comments 
were made by respondents. Overall, more positive (2,528) 
than negative (1,969) comments were made, a ratio of 
1:0.78 (table 5). Positive comments (average 24 words) 
tended to be shorter, more generic and less detailed 
than negative comments (average 43 words). Respon-
dents made more positive than negative comments for all 
comment boxes except comment box 1 (the lead-up to 
diagnosis), where a significantly greater number of nega-
tive comments were made (571 negative, 369 positive, 
χ2(6)=200.6, p<0.001).
Qualitative findings
Positive comments
Themes emerging from the positive comments are 
illustrated with quotes in table 2. The majority of these 
comments reflected a generally positive experience, with 
respondents describing their care as good, very good or 
excellent. Many of these positive comments lacked any 
detail as to which aspects of the experience were particu-
larly valued by patients.
Table 2 Summary of the positive themes
Themes
Number of 
comments
Quotes
(Gender, age bracket, type of cancer) 
Generally positive experience 1995 All in all very good.
Female, 66–75, breast cancer
Good support 738 Clinical nurse was extremely helpful and gave me great friendship and support 
during this horrendous time. A great font of knowledge with financial help, the 
benefits I could apply for. She assisted in the filling out of complicated forms. A 
real treasure.
Female, 66–75, haematological cancer
Information 508 I had/have an excellent consultant surgeon by the name of Mr (name removed). 
I have had the best of care and attention from him. Despite being an extremely 
busy man, he always has time to spend with me and my wife at appointments. 
He explains everything very clearly and answers our questions thoroughly. In 
my opinion I couldn't ask for a better man to care for me.
Male, 66–75, colorectal/lower gastrointestinal cancer
Good clinical care 362 Despite complications and infections arising from my prostate removal the care 
and attention that I received from (name removed) and his team of doctors and 
nurses was of the highest order. I could have no complaints. Very impressive 
urology care team.
Male, 66–75, prostate cancer
Efficient processes 279 I was admitted to the (hospital name removed) after presenting to my GP with 
(condition removed). Had ultrasound, MRI and CT scan all within 5 days and 
due to tumour was transferred to the (hospital name removed), scoped and 
biopsy taken and I had my full diagnosis within 3 weeks and chemotherapy 
started within 5 weeks.
Male, 51–65, upper gastrointestinal cancer
Trust in the system 81 Discussions were business-like. Facts were presented to me, questions 
answered and information was very clear and decisions agreed. It was a very 
democratic, and respectfully conducted process.
Male, 66–75, upper gastrointestinal cancer
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Table 4 Demographic details of all respondents and those that left at least one comment
Respondent characteristics
Left at least one comment Respondents who left no comment
Number of 
respondents Percentage
Number of 
respondents Percentage
Age, years
  16–34 47 2 38 2
  35–44 130 5 52 3
  45–54 369 14 241 12
  55–64 649 25 487 24
  65–74 864 34 766 37
  Age 75+ 512 20 486 23
χ2(5)=37.3, p≤0.001
Gender
  Female 1520 59 1139 54
  Male 1072 41 973 46
χ2(1)=10.5, p=0.001
Sexual orientation
  Heterosexual 2517 99 2028 99
  Bisexual, gay or lesbian, or other 27 1 20 1
No significant difference
Ethnic origin
  White 2558 99 2077 98
  All other ethnic origins 29 1 33 2
No significant difference
Employment status
  Don’t work due to illness or disability 227 9 156 7
  Other 42 2 47 2
  Retired 1568 60 1363 64
  Unemployed/looking for work 21 1 22 1
  Work full time/in full time education 458 18 347 14
  Work part-time 289 11 192 9
χ2(5)=14.5, p=0.013
SIMD quintile (2012)
  (most deprived) 1 327 13 381 19
  2 453 18 351 18
  3 530 21 381 19
  4 572 23 432 22
  (least deprived) 5 644 25 435 22
χ2(4)=35.8, p≤0.001
Tumour group
  Brain/central nervous system 21 1 18 1
  Breast 659 25 528 24
  Colorectal/lower gastrointestinal 427 16 294 14
  Gynaecological 213 8 146 7
  Haematological 215 8 164 8
  Head and neck 148 6 116 5
  Lung 163 6 129 6
Continued
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Where respondents did give more detail about the 
aspects of care which gave them a positive experience, the 
most common theme was good support. Within this theme, 
respondents described being cared for both practically 
and emotionally, and being treated as an individual. 
Comments about good support related to care received 
from NHS staff, in particular from clinical nurse special-
ists and GPs, and also to support received through a range 
of charities. However, many participants commented that 
they had found out about the support available from char-
ities through word of mouth, for example, from other 
patients rather than having been signposted by NHS staff.
Another common positive theme was information, with 
participants describing how much they valued receiving 
clear information and thorough explanations of their 
cancer and treatment, including treatment options. 
The manner in which information was conveyed was 
also important, with participants appreciating sensitive 
communication from staff who gave them the time to 
process information and ask questions.
Further positive comments related to receiving good 
clinical care. Respondents commented on treatment going 
well, good symptom management and having faith in 
the clinical competence of staff. Participants expressed 
their confidence when they felt that they were being 
treated by a cohesive team, appreciating communication 
and continuity of care. Many participants were relieved 
and grateful that their GP had identified symptoms and 
organised diagnostic testing for cancer.
Respondents commented positively on efficient processes, 
mainly in relation to the speed of treatment, both in 
referral for tests before diagnosis, and in the efficient 
running of outpatient clinics. The smooth running and 
speed of various national screening programmes was also 
commented on favourably.
The final distinct positive theme suggested by the data 
was trust in the system, with respondents particularly valuing 
knowledgeable staff, and a collaborative and inclusive 
approach to decision making about treatment.
Negative comments
Four broad themes emerged from analysis of the nega-
tive comments in the survey as depicted in figure 1. A 
number of subthemes were identified within these four 
overarching themes, and these are illustrated by selected 
quotes in table 3. The subthemes clearly suggested that 
negative experiences were related to (1) Patients not 
feeling confident or secure within the system, or (2) 
Patients not feeling that their individual needs were met. 
Other subthemes related to participants’ perceptions of 
the way care was organised and these were grouped into 
(3) the way services and environments are set up (which 
we termed structures), and (4) the organisation of care 
and treatment (which we termed processes).
Respondent characteristics
Left at least one comment Respondents who left no comment
Number of 
respondents Percentage
Number of 
respondents Percentage
  Prostate 290 11 302 14
  Sarcoma 20 1 14 1
  Skin 70 3 59 3
  Upper gastrointestinal 118 4 71 3
  Urological 173 6 135 6
  Other/tumour group unknown 146 5 196 9
  χ2(12) = 42.9, p≤0.001
Table 4 Continued 
Table 5 First order code by comment box
Comment box Positive Negative Factual/neutral
Irrelevant/ 
miscellaneous
Both positive 
and negative Total
1 369 571 597 22 114 1673
2 338 260 242 12 39 891
3 499 232 76 8 83 898
4 478 293 88 144 117 1120
5 292 153 46 143 44 678
6 197 105 65 211 48 626
7 355 355 94 45 226 1075
Total 2528 1969 1208 585 671 6961
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Although there were not as many negative comments 
as there were positive, the negative comments were much 
more specific and detailed, and gave a very clear picture 
of where improvement strategies could focus in order to 
enhance patients’ experiences of cancer care.
The theme with the most negative comments, ‘Not 
feeling confident or secure within the system’, represented 
a number of subthemes (table 3). The most common 
subtheme was generated from comments about receiving 
poor care, particularly inadequate symptom management. 
Comments suggested that care was perceived to be poorer 
at night and at weekends, as well as on general rather than 
specialist wards. Many respondents described deficiencies 
in care and support after treatment had ended, including 
not receiving sufficient contact or emotional support and 
feeling isolated and alone, not being sure who to contact 
when they had cancer or treatment related problems, not 
receiving enough help with management of side effects 
and feeling that they received inadequate information 
about ongoing monitoring. A concern for some respon-
dents was the lack of contact or support they received 
from their GP practice, community nurse or district 
nurse. Concerns about the role of primary care in the 
cancer experience were also reflected in comments about 
difficulties getting into the system. The majority of comments 
in this subtheme described the delays and multiple visits 
to GPs experienced by some participants before they 
were referred for diagnostic tests. However, other issues 
with the lead-up to diagnosis were not with primary 
care, but with participants' understanding of diagnostic 
testing, reflected in comments about lack of faith in the 
system. Some participants described their confusion that 
diagnostic tests or screening had not identified cancer. 
Many respondents also lost confidence in the system 
when they were given inconsistent or incorrect information 
by different health professionals involved in their care. 
Others described a feeling of being in limbo because of 
waits and delays between one stage of treatment and the 
next, and a lack of communication during these uncer-
tain and difficult times.
The second core theme which emerged was ‘Not feeling 
that individual needs were met’. Within this theme the greatest 
number of comments related to information not being 
sufficient or specific enough to meet patients’ individual 
needs. Some patients were clearly overwhelmed by the 
amount of information they received, but most expressed 
a wish that they had been given more detailed and honest 
information about treatment options, side effects and 
self-management, as well as about other services they could 
access for specific support and information, for example, 
on financial issues. Many participants gave examples of 
poor communication during their experience of being 
treated for cancer, illustrating incidents where members 
of staff were perceived as insensitive, rude or dismis-
sive. Other communication problems related to the way 
some patients had been told they had cancer, with many 
feeling that the conversation was vague, rushed or not 
handled sensitively. Lack of emotional support was also 
mentioned by many respondents, particularly if they did 
not have access or were not referred to a clinical nurse 
specialist or Macmillan service. Some felt they had not 
been listened to, or they experienced a lack of continuity 
in support (eg, when staff changed, went on holiday or 
were not available). Many participants expressed feelings 
of isolation and loneliness, both during and particularly 
after treatment, because they did not receive the support 
they needed.
The negative impact of structures and processes on experi-
ences of cancer care was expressed through a considerable 
number of comments related to the way in which services 
were set up and organised. The most common issue 
under the theme of processes (the organisation of care 
and treatment) was waits and delays, covering waiting 
for appointments to be scheduled, waiting between 
Figure 1 Negative aspects of care.
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one thing and the next thing happening, and waiting 
on the day of appointments. Many patients specifically 
mentioned waiting on the day of chemotherapy appoint-
ments, with some describing waits of several hours before 
their chemotherapy commenced. Other unsatisfactory 
processes related to experiences of ineffective and unreli-
able communication systems. Many participants described 
inefficient administrative procedures, including delays in 
letters being received by or sent to GPs, appointments not 
being arranged, and appointments being cancelled or 
postponed without adequate communication. One of the 
most common sources of concern was that monitoring 
and follow-up appointments were not always arranged in 
line with the expectations that had been set by clinicians, 
leaving considerable room for uncertainty and worry. 
Other experiences included notes going missing, prob-
lems with call handling, poor communication between 
departments and different sites not having access to 
full notes, all contributing to participants feeling passed 
around or feeling that their care was fragmented.
Participants also described a number of ways in which 
aspects of the care environment impacted negatively on 
their experiences. Particular issues highlighted under 
the theme of structures were related to lack of privacy, bed 
availability or aspects of comfort on wards (eg, meals, 
bathrooms), difficulties with transport and inadequate 
staffing levels.
QuAntItAtIve AnAlysIs
Differences in the proportion of positive to negative 
comments by demographics (gender, age, socioeconomic 
status, employment status, tumour group and health 
board) were analysed using χ2 tests for each of the seven 
comment boxes. The proportion of positive comments 
within each subcategory for age, employment status and 
tumour group is presented in table 6.
There were significant differences in the experience of 
cancer care by age and employment status across the first 
five comment boxes (table 6). Younger participants were 
less likely to report a positive experience compared with 
participants over age 66 years, across all comment boxes 
except comment box 6 (chemotherapy/radiotherapy). A 
greater proportion of participants who worked full time, 
or who didn’t work because they were either unemployed, 
a student or had an illness or disability, were negative 
about their experiences of cancer care across the first five 
comment boxes, whereas a greater than expected propor-
tion of participants who were retired were positive about 
their experiences of cancer care.
There were significant differences in particular aspects 
of the experience of cancer care by tumour group (table 6). 
The proportion of positive to negative comments made in 
response to each comment box was compared for each of 
the cancer groups. There was a trend for participants with 
less common cancer types (eg, haematological, head and 
neck, gynaecological, brain, central nervous system (CNS), 
sarcoma and urological cancers) to make proportionately 
more negative comments about their experience of the 
lead-up to diagnosis (comment box 1). There was a 
trend for respondents with breast and urological cancers 
to report a proportionately greater number of negative 
experiences about their involvement in decision making, 
the support they received and inpatient care (comment 
boxes, 2, 3 and 4). Participants with lung cancer tended 
to make a greater proportion of positive comments about 
their experiences of support received, and inpatient and 
outpatient care. Finally, participants with upper gastro-
intestinal and head and neck cancers made a greater 
proportion of negative comments about their experience 
of day patient/outpatient care (comment box 5).
There were significant gender differences in the 
proportion of positive to negative comments for the 
way decisions were made about treatment (male, n=164 
(66.9%) positive; female, n=169 (49.3%) positive; 
χ2(1)=18.2, p≤0.001), and participants’ experience of 
the support they received (male, n=213 (79.5%) positive; 
female, n=272 (61.0%) positive; χ2(1)=26.3, p≤0.001), 
with men being more likely than women to report a posi-
tive experience. This gender difference is significant in 
both participants with and without breast cancer, indi-
cating it is not merely a breast cancer effect. There were 
no significant gender differences across any of the other 
comment boxes.
The only significant difference in the proportion of 
positive to negative comments by socioeconomic status 
was for inpatient care (comment box 4), where the least 
deprived participants made a greater proportion (46.6%) 
of negative comments about their experience than partic-
ipants from any of the other groups (34.8%, 28.2%, 33.1%, 
38.9% for Scottish Index of Multiple Deprivation (SIMD) 
group 1–4, respectively) (χ2(4)=13.3, p=0.10).21
There were no significant differences in the propor-
tion of positive to negative comments across any of the 
demographics for comment box 6 (chemotherapy/
radiotherapy treatment) or comment box 7 (anything 
else about the experience of cancer care), except for an 
age effect in comment box 7 (with a greater proportion 
of negative comments in younger people, 16–35 years, 
n=6 (31.6%) positive; 36–50 years, n=36 (40.9%) positive; 
51–65 years, n=126 (45.3%) positive; 66–75 years, n=116 
(55%) positive; 76 years and over, n=63 (63%) positive; 
χ2(4)=16.8, p=0.002).
There were no significant differences in the propor-
tion of positive to negative comments across any of the 
comment boxes by health board.
dIscussIon
This is the first time that a nationwide survey has been 
conducted of experience of care of Scottish patients with 
cancer. Providing seven free-text comment boxes gave 
participants the opportunity to expand on particular 
aspects of their care which were important to them or had 
an impact on their overall experience. The analysis of the 
comments revealed that the ratio of positive to negative 
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comments was 1:0.78, indicating that while the majority 
of patients had a positive experience of care, a significant 
minority had a negative experience, and this was particu-
larly the case in the lead-up to diagnosis. Previous analysis 
of the closed-ended questions from the survey found that 
94% of respondents rated their overall experience of care 
as good or very good.15 Analysis of the free-text comments 
provided a much greater insight into the specific prob-
lems participants had encountered during their cancer 
care. The generic nature of positive comments meant that 
there was less detailed analysis of the aspects of care which 
patients value. However, good support, clear information, 
good clinical care and efficient processes all emerged 
as positive themes for participants. Negative comments 
tended to be more detailed and specific and there-
fore provided richer material for analysis. Four themes 
emerged from the negative comments, highlighting the 
importance to people with cancer of feeling confident in 
the system and being treated as an individual. Analysis of 
the negative comments revealed that many participants 
had experienced problems with the way care was organ-
ised and services were set up.
Table 6 Proportion of positive comments by comments box 1–5
Lead-up to 
diagnosis
(box 1)
The way decisions 
were made about 
treatment (box 2)
The support you 
received (box 3)
Inpatient care 
(box 4)
Day or outpatient 
care (box 5)
Positive
N (%)
Positive
N (%)
Positive
N (%)
Positive
N(%)
Positive
N (%)
Age, years
  16–35 6 (22.2) 4 (26.7) 9 (60.0) 8 (47.1) 2 (25.0)
  36–50 41 (29.5) 40 (50.0) 60 (60.0) 50 (53.2) 30 (46.9)
  51–65 118 (32.6) 115 (48.1) 178 (62.5) 165 (55.6) 109 (61.9)
  66–75 133 (46.0) 115 (67.6) 173 (75.9) 174 (70.2) 98 (76.6)
  76 and over 60 (60.6) 55 (71.4) 63 (75.9) 73 (74.5) 49 (75.4)
  χ2(4)=40**   χ2(4)=29**   χ2(4)=16.3**   χ2(4)=23.5**   χ2(4)=26.3**
Employment status
  Work full time/in full 
time education
51 (26.3) 62 (53.4) 76 (58.5) 74 (51.7) 44 (50.0)
  Work part-time 53 (40.5) 41 (55.4) 66 (67.3) 53 (55.8) 37 (60.7)
  Unemployed/ looking 
for work
4 (44.4) 1 (12.5) 1 (14.3) 1 (25.0) 1 (33.3)
  Retired 224 (46.8) 198 (63.3) 289 (75.1) 297 (69.1) 173 (75.5)
  Don’t work due to 
illness or disability
21 (23.3) 25 (41.0) 48 (59.3) 42 (51.9) 23 (50.0)
  χ2(4)=34.8**   χ2(4)=18.5**   χ2(4)=26.6**   χ2(4)=22.9**   χ2(4)=26.3**
Tumour group
  Lung 24 (46.2) 20 (64.5) 31 (83.8) 40 (85.1) 15 (88.2)
  Prostate 41 (48.8) 42 (55.3) 61 (83.6) 37 (58.7) 30 (73.2)
  Upper gastrointestinal 16 (40.0) 23 (76.7) 21 (63.6) 22 (68.8) 5 (50.0)
  Colorectal/lower 
gastrointestinal
70 (46.1) 61 (69.3) 90 (75.0) 91 (62.8) 35 (63.6)
  Breast 100 (41.7) 74 (46.8) 112 (55.7) 111 (55.0) 65 (54.6)
  Haematological 22 (29.7) 24 (70.6) 40 (72.7) 31 (75.6) 46 (82.1)
  Head and neck 17 (29.8) 25 (56.8) 36 (83.7) 31 (66.0) 12 (52.2)
  Gynaecological 28 (31.8) 24 (58.5) 39 (68.4) 47 (61.0) 34 (79.1)
  Brain/CNS/
  Sarcoma
7 (33.3) 8 (66.7) 11 (68.8) 8 (50.0) 6 (66.7)
  Skin 11 (36.7) 6 (40.0) 11 (91.7) 9 (64.3) 11 (61.1)
  Urological 16 (27.6) 19 (47.5) 25 (58.1) 34 (60.7) 18 (62.1)
  χ2(10)=18.5*   χ2(10)=24**   χ2(10)=40**   χ2(10)=20.5*   χ2(10)=24.9**
*p<0.05, **p<0.01.
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Although nothing emerged from the inductive thematic 
analysis about differences in experience of care as a result 
of sociodemographic characteristics, analysis of the posi-
tive and negative comments indicated that participants 
who were younger, who worked full time or who had 
certain types of cancer were more likely to report nega-
tive experiences. The demographic trends identified in 
this analysis were similar to the (English) National Cancer 
Patient Experience Survey 2011–2012 which found that 
female and younger patients are less likely to be positive 
about their cancer experience.22 Both the qualitative 
and quantitative results of the SCPES found that patients 
from the least deprived areas were more negative about 
their experience of inpatient care.15 Variations in the 
experience of care between demographic groups could 
represent differences in needs, expectations or the provi-
sion of care.22 While the analysis indicates that certain 
types of patients have a more negative experience of care, 
a cross-sectional survey cannot provide an explanation 
for differences by demographics, and further research is 
required to understand why certain patient characteristics 
are associated with reporting more negative experiences 
of care.
A strength of this study was the structured approach 
followed to analyse the large data set.20 However, the 
qualitative researcher is part of the analysis process, 
and makes subjective decisions about coding and the 
creation of subthemes and themes. While the analysis was 
conducted by a team of independent researchers and the 
process followed was transparent and rigorous, there will 
always be an element of subjectivity to qualitative analysis. 
The free-text comments formed part of a larger survey 
which also included closed-ended questions about patient 
experience. A limitation of this analysis is that data access 
issues meant we were not able to compare the quantita-
tive and qualitative data. A further limitation was that no 
information was gathered about the health status of partic-
ipants. Sending surveys to an entire cohort of patients 
maximised the opportunities to capture a wide range 
of experiences, and including seven free-text comment 
boxes placed throughout the survey gave participants the 
opportunity to reflect and comment on different stages 
of the cancer journey. The free-text questions focused 
on experiences of, rather than satisfaction with, care, 
removing the risks inherent in making assumptions about 
how patients evaluate satisfaction.23 However, there is a 
risk of bias in free-text responses towards patients who 
are more literate, have English as a first language, and 
who do not have learning difficulties. We found signifi-
cant differences between participants who left a free-text 
comment and those who did not, with women, part-time 
and middle-aged respondents leaving a greater propor-
tion of comments than expected, and respondents from 
the most deprived areas and those with prostate cancer 
leaving fewer comments than expected. Highlighting the 
importance of gathering patients’ views on their health-
care may reduce intimidation and improve response rates 
from hard-to-reach patient groups.24
Although most of the issues within the subthemes were 
covered at some point in the closed-ended questions in the 
survey, participants often brought up issues, unprompted, 
in the qualitative comments before they had arisen in 
the questionnaire. For example, although the first three 
comment boxes and their preceding quantitative ques-
tions didn’t ask specific questions about continuity of 
care, or being treated as an individual, both came out 
strongly in participants’ comments. The content of the 
comment boxes also reflected specific issues covered in 
the preceding closed-ended questions. However, within 
the comments, participants gave much more depth and 
description about the issues.
SCPES was based on a survey which has been previously 
conducted in England and Wales, which asked partic-
ipants what was particularly good, and what could have 
been improved about their cancer experience.18 Anal-
ysis of the free-text comments of London participants25 
and Welsh participants,14 revealed a greater proportion 
of positive to negative comments (1:0.51 London; 1:0.61 
Wales) than in SCPES (1:0.78). This effect may be because 
SCPES did not specifically ask patients to describe what 
they found good about their care. There were many 
similarities in the themes identified in all three surveys, 
including that patients commented on receiving poorer 
care at nights and at the weekend; and on issues with the 
role of primary care in cancer diagnosis. Many partici-
pants in SCPES noted poorer care when receiving care 
from staff who they perceived not to be cancer specialists. 
Analysis of English survey results indicated that patients in 
Trusts which had more cancer specialist nurses, reported 
a better experience of care coordination and emotional 
support.26 The issues around lack of involvement and 
choice in decision making, being given inconsistent or 
inappropriate information, and lack of signposting to 
support services, which were highlighted in SCPES, did 
not appear to emerge strongly in the free-text analysis of 
other surveys. It is not clear whether this is an effect of 
the difference in free-text questions and analysis between 
the surveys or if it reflects actual differences in the expe-
rience of patients with cancer between these countries. 
Nonetheless, communication emerged as a theme in all 
three surveys, both within health services and between 
health professionals and patients. Designing interven-
tions to improve communication is a critical challenge in 
improving the delivery of cancer care.27 28
Two major aims of the current Scottish Government’s 
cancer strategy are to improve cancer detection and 
aftercare.29Our analysis suggests that many patients 
have significant problems with these two phases of 
care at present. There have been guidelines for the 
referral of suspected cancer cases in Scotland since 
2002,30 which have been revised in light of new research 
in 2007 and 2014;31 the National Institute for Health 
and Care Excellence also published suspected cancer 
referral guidelines in 2015.32 The Scottish Govern-
ment launched the Detect Cancer Early Programme 
in 2012, developing projects with the NHS to increase 
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screening uptake, increase diagnostic capacity, and 
work with GPs to promote referral or investigation for 
suspected cancer cases.33 Free-text comments in SCPES 
suggest that patients were less happy with the lead-up 
to diagnosis than at any other point in their treatment. 
Some made positive comments about the efficiency of 
national screening programmes, however, the majority 
of respondents were negative about the lead-up to 
diagnosis, particularly commenting on experiencing 
long waits and delays, having difficulty getting into the 
system, and poor communication. The timing of SCPES 
may be a factor in people having a less good experience 
of the lead-up to diagnosis, with participants for the 
survey having received a diagnosis between July 2013 
and March 2014. It is possible the Detect Cancer Early 
Programme had not yet had an impact on processes 
around diagnosis for the cohort in this study. However, 
we found that patients with less common cancer types 
made a greater proportion of negative comments 
about the lead-up to diagnosis. The Detect Cancer 
Early Programme has focused on breast, colorectal and 
lung cancers, as they are the most common cancers 
in Scotland;34 our results suggest that patients with 
less common cancers are not benefiting from similar 
improvements to the early diagnosis system. Further, 
referral guidelines, and improvements in the capacity of 
screening and diagnostic services are aimed at tackling 
processes, rather than the patients’ experiences of those 
processes. One of the main problems with the lead-up 
to diagnosis identified in this study was around poor 
communication at the time of diagnosis, with partici-
pants describing feeling that staff did not listen to them, 
or that they were not given information appropriate to 
their needs at that time. Many participants described 
feeling confused and anxious as a result of the way 
they were told about their diagnosis, and others expe-
rienced delays and confusion around diagnostic testing 
and once they got into the hospital system. Results from 
SCPES suggest that improving diagnostic pathways for 
less common cancers, and improving communication 
at the time of diagnosis would enhance the experience 
of this particularly worrying and stressful time. These 
results chime with those of another recently published 
analysis of free-text comments, which illustrates that 
patients may move backwards and forwards within the 
diagnostic pathway and that this is often complex and 
difficult to navigate.35
The relatively large proportion of negative comments 
indicate that not all patients with cancer in Scotland 
are receiving person-centred care. From the patients' 
perspective, all stages of the care continuum and 
every interaction with services have an impact on their 
experience. This survey identified problems with both 
interactions with health professionals and services and 
linkages between services. Participants described inter-
acting with many different services, including GPs, 
charities, cancer services and other specialist services—
coordination of care between these services arose as 
an issue in multiple free-text comments, suggesting 
problems with fragmentation of care, lack of sign-
posting, inconsistent information and the patient not 
knowing who to contact. Understanding and improving 
processes for administration, communication and coor-
dination between services is vital to ensure a positive 
and high-quality experience for the patient.27 While 
improvement at an individual service level is important 
to enhance clinical effectiveness and safety, improve-
ment efforts also need to take a ‘whole systems’ view 
in order to impact on the overall patient experience. 
A recent review of the relationship between integrated 
care and experience of patients with cancer found a posi-
tive association between greater integration of care and 
both patient experience, and professionals’ behaviour 
and attitudes in cancer care, identifying the impor-
tance of (1) having a case manager or navigator, (2) 
the engagement of a multidisciplinary team in care and 
treatment, and (3) a continuous relationship between 
the case manager and healthcare professionals.36 The 
results of SCPES identified that participants were 
particularly positive about their experience when they 
felt they received treatment from a cohesive team, and 
negative about their experience when they felt they did 
not have a named contact who was available to help 
them with aspects of their care and provide information 
in a responsive and meaningful way.
SCPES provides detailed information about the expe-
rience of cancer care at a system level in Scotland. 
However, a survey of this nature is anonymous and 
there is a time lag between the experience of care and 
analysis, meaning the results have no direct impact for 
individual participants. Also, due to the distributed care 
of patients with cancer, it can be difficult to identify 
particular parts of the service which would benefit from 
organisational change. The measurement of patient 
experience should be timely and focused in order to 
provide information which is actionable in specific 
services.37 At an individual level, measurement of patient 
experience could provide valuable insight into issues 
with an individual’s experience of care and provide 
real time feedback to help identify and resolve unmet 
needs. The SCPES results suggest that when patients 
have a negative experience of care their confidence in 
the system is shaken and they may feel more vulnerable 
when treatment comes to an end. Macmillan’s Recovery 
Package advocates that all patients with cancer should 
receive a holistic needs assessment and care plan at key 
points of the cancer pathway, and a cancer care review 
completed by primary care within 6 months of the GP 
being informed of a patient’s cancer diagnosis.38 If 
rolled out for all patients, these conversations could 
provide an opportunity to assess and monitor patients’ 
experience of care and provide a mechanism to resolve 
issues for individual patients as they move through the 
care pathway. Sensitive, reliable and service-focused 
tools are needed to measure the experience of patients 
with cancer in real time to facilitate this process.37 39
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The analysis of the free-text comments in SCPES has 
highlighted aspects of cancer care which are particu-
larly important to patients. While many patients have a 
positive experience of cancer care, there are some key 
factors which contribute to negative experiences at all 
stages of the cancer pathway. The results of the survey 
provide important details of the experiences of care 
which may matter most to patients, suggesting areas 
for service improvement which will communicate to 
patients as individuals, and inspire greater confidence 
in the system of care. Our analysis also points to partic-
ular aspects of care which need attention, including the 
experience of the lead-up to diagnosis, the integration 
of care and monitoring patient experience in real time 
in order to ensure that we are truly responsive to the 
needs of people with cancer.
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